CD19 CAR-T Cell Therapy: High Efficacy in Autoimmune Diseases

被引：0
|
作者：
Brudermanns, Britta
机构：
来源：
TRANSFUSIONSMEDIZIN | 2024年 / 14卷 / 03期
关键词：
D O I：
10.1055/a-2313-4535
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The treatment of autoimmune diseases such as systemic lupus erythematosus (SLE), idiopathic inflammatory myopathies and systemic sclerosis often requires long-term immunosuppression. F. M & uuml;ller and colleagues now investigated the resetting of aberrant autoimmunity by deep depletion of B cells as a potential strategy to achieve a sustained drug-free remission.
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [41] Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
    Alyssa Sheih
    Valentin Voillet
    Laïla-Aïcha Hanafi
    Hannah A. DeBerg
    Masanao Yajima
    Reed Hawkins
    Vivian Gersuk
    Stanley R. Riddell
    David G. Maloney
    Martin E. Wohlfahrt
    Dnyanada Pande
    Mark R. Enstrom
    Hans-Peter Kiem
    Jennifer E. Adair
    Raphaël Gottardo
    Peter S. Linsley
    Cameron J. Turtle
    Nature Communications, 11
  • [42] Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
    Cao, Xing-Yu
    Li, Jing-Jing
    Lu, Pei-Hua
    Liu, Kai-Yan
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (03) : 315 - 329
  • [43] Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation
    Xing-yu Cao
    Jing-jing Li
    Pei-hua Lu
    Kai-yan Liu
    International Journal of Hematology, 2022, 116 : 315 - 329
  • [44] TET2 DISRUPTION ENHANCES THE EFFICACY OF CD19 CAR T-CELL THERAPY
    不详
    CANCER DISCOVERY, 2018, 8 (07) : 793 - 793
  • [45] Development of a translatable CD19 CAR-T platform for drug discovery
    Kelsey, Lauren
    Self-Fordham, Jezrom
    Oswald, Eva
    Aylott, Ilona
    Rocca, Daniel
    Nunan, Robert
    Harris, David
    Schueler, Julia
    Jenkinson, Rhiannon
    CANCER RESEARCH, 2022, 82 (12)
  • [46] High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy
    Hirayama, Alexandre V.
    Gauthier, Jordan
    Hay, Kevin A.
    Voutsinas, Jenna M.
    Wu, Qian
    Pender, Barbara S.
    Hawkins, Reed M.
    Vakil, Aesha
    Steinmetz, Rachel N.
    Riddell, Stanley R.
    Maloney, David G.
    Turtle, Cameron J.
    BLOOD, 2019, 134 (07) : 636 - 640
  • [47] CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up
    Mueller, Fabian
    Taubmann, Jule
    Bucci, Laura
    Wilhelm, Artur
    Bergmann, Christina
    Voelkl, Simon
    Aigner, Michael
    Rothe, Tobias
    Minopoulou, Ioanna
    Tur, Carlo
    Knitza, Johannes
    Kharboutli, Soraya
    Kretschmann, Sascha
    Vasova, Ingrid
    Spoerl, Silvia
    Reimann, Hannah
    Munoz, Luis
    Gerlach, Roman G.
    Schaefer, Simon
    Grieshaber-Bouyer, Ricardo
    Korganow, Anne-Sophie
    Farge-Bancel, Dominique
    Mougiakakos, Dimitrios
    Bozec, Aline
    Winkler, Thomas
    Kroenke, Gerhard
    Mackensen, Andreas
    Schett, Georg
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (08): : 687 - 700
  • [48] Two years later: CD19 CAR-T going the distance
    Darnell, Eli P.
    Frigault, Matthew J.
    BLOOD, 2024, 143 (05) : 379 - 380
  • [49] Challenge of cryopreservation for gmp grade CD19 CAR-T cells
    Gong, Wenjie
    Wang, Lei
    Wang, Sanmei
    Neuber, Brigitte
    Sellner, Leopold
    Schubert, Maria-Luisa
    Hueckelhoven-Krauss, Angela
    Kunz, Alexander
    Gern, Ulrike
    Michels, Birgit
    Hinkelbein, Mandy
    Mechler, Stefanie
    Richter, Petra
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Schmitt, Anita
    BONE MARROW TRANSPLANTATION, 2019, 54 : 186 - 187
  • [50] Bone Marrow Fibrosis Is Associated with Non-Response to CD19 CAR-T Therapy
    Anil, Joshua
    Lytle, Andrew
    Alnemri, Ahab
    Lockhart, Brian
    Pillai, Vinodh
    BLOOD, 2022, 140 : 9194 - 9195
12345